EPO and ischemic stroke: EPO and LTF were reported to show strong protein-protein interaction with collaborative anti-inflammatory properties69 and modified, optimized versions of both these proteins have been tested experimentally as neuroprotective agents in ischemic stroke and intracerebral hemorrhage, and, for some, patented (WO2006120030A1)72–74.